DADieneke Z. B. van Asselt

Dieneke Z. B. van Asselt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dieneke Z. B. van Asselt has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • E. Droogsma

    Geriatric Medicine, Medical Centre Leeuwarden, Po Box 888 Leeuwarden 8901 BR, The Netherlands

    3 shared publications
  • J. H. M. Van Steijn

    Geriatric Medicine, Medical Centre Leeuwarden, Leeuwarden, THE NETHERLANDS

    3 shared publications
  • E. J. Huinink

    Geriatric Medicine, Medical Centre Leeuwarden, Leeuwarden, THE NETHERLANDS

    2 shared publications
  • T. Schuur

    Geriatric Medicine, Medical Centre Leeuwarden, Leeuwarden, THE NETHERLANDS

    2 shared publications
  • Andre Janse

    Geriatric Medicine , Hospital Gelderse Vallei , Ede , The Netherlands

    1 shared publication
  • Armin Zittermann

    University of Bochum, Georgstraße 11, 32545 Bad Oeynhausen, Germany

    1 shared publication

Latest Publications

  • Long-term Course of Alzheimer Disease in Patients Treated According to the Dutch Dementia Guideline at a Memory Clinic

    by Erika Droogsma, Dieneke van Asselt, Jolanda van Steijn, Marjolein Diekhuis, Nic Veeger, Peter P. De Deyn

    There is little knowledge of the long-term course of Alzheimer disease (AD) in light of current pharmacological and nonpharmacological interventions provided in a "real-life" setting.The Frisian Alzheimer's Disease Cohort study is a "real-life" study of the course of AD in patients (n=576) treated with pharmacological (ie, cholinesterase inhibitors) and nonpharmacological (ie, case management, respite care) interventions. Disease course was described by changes in cognition (Mini Mental State Examination, clock-drawing test) and number of types of professional care applying a repeated-measures analysis using a marginal model (population-based average model). In addition, behavioral and psychological symptoms, and proportions of nursing home admissions and deaths were investigated.During 3.5 years, the average Mini Mental State Examination decreased from 22.24 to 18.91, the clock-drawing test score increased from 3.38 to 4.05, the number of types of professional care increased from 0.85 to 2.64, and the patients with behavioral and psychological symptoms increased from 29.0% to 70.2%. The proportion of patients admitted to a nursing home was 40.8% and 41.0% died.Cognition and behaviour of AD patients deteriorated accompanied with an increase in care-dependency during 3.5 years. Nevertheless, compared with the precholinesterase inhibitor era, current pharmacological and nonpharmacological interventions appear to slow cognitive decline, which emphasizes that they seem to have a favorable effect.


  • Open Access

    The relationship of weight change trajectory with medial temporal lobe atrophy in patients with mild Alzheimer’s disease: results from a cohort study

    by Erika Droogsma, Dieneke van Asselt, Hanneli Bieze, Nic Veeger, Peter Paul De Deyn

    Weight loss has been described in 20% to 45% of patients with Alzheimer’s disease (AD) and has been associated with adverse outcomes. Various mechanisms for weight loss in AD patients have been proposed, though none has been proven. This study aimed to elucidate a mechanism of weight loss in AD patients by examining the hypothesis that weight loss is associated with medial temporal lobe atrophy (MTA). Patients from the Frisian Alzheimer’s disease cohort study (a retrospective, longitudinal study of 576 community-dwelling AD patients) were included when a brain MRI was performed on which MTA could be assessed. To investigate the hypothesis that weight loss is associated with MTA, we investigated whether the trajectory of body weight change depends on the severity of MTA at the time of diagnosis (that is baseline). We hypothesized that patients with more severe MTA at baseline would have a lower body weight at baseline and a faster decrease in body weight during the course of the disease. The generalized linear mixed model (GLMM) was used to determine the relationship of weight change trajectory with MTA severity. In total, 214 patients (median age 79 years, median MMSE 23, mean weight 73.9 kg) were included. Patients with moderate, severe or very severe MTA at baseline weighed 3.2 to 6.8 kg more than patients with no or mild MTA. During the 3.5 years, patients gained on average 1.7 kg in body weight, irrespective of the severity of their MTA at baseline. We found no evidence that MTA is associated with weight loss in AD patients. Moreover, contrary to what was expected, AD patients did not lose but gained weight during follow-up.


  • Open Access

    Selected Nutrients and Their Implications for Health and Disease across the Lifespan: A Roadmap

    by Szabolcs Péter, Manfred Eggersdorfer, Dieneke Van Asselt, Erik Buskens, Patrick Detzel, Karen Freijer, Berthold Koletzko, Klaus Kraemer, Folkert Kuipers, Lynnette Neufeld, et al.

    Worldwide approximately two billion people have a diet insufficient in micronutrients. Even in the developed world, an increasing number of people consume nutrient-poor food on a regular basis. Recent surveys in Western countries consistently indicate inadequate intake of nutrients such as vitamins and minerals, compared to recommendations. The International Osteoporosis Foundation’s (IOF) latest figures show that globally about 88% of the population does not have an optimal vitamin D status. The Lancet’s “Global Burden of Disease Study 2010” demonstrates a continued growth in life expectancy for populations around the world; however, the last decade of life is often disabled by the burden of partly preventable health issues. Compelling evidence suggests that improving nutrition protects health, prevents disability, boosts economic productivity and saves lives. Investments to improve nutrition make a positive contribution to long-term national and global health, economic productivity and stability, and societal resilience.


  • Open Access

    Nutritional status of community-dwelling elderly with newly diagnosed Alzheimer's disease: Prevalence of malnutrition and the relation of various factors to nutritional status

    by E. Droogsma, D. Z. B. Van Asselt, C. J. M. Scholzel-Dorenbos, J. H. M. Van Steijn, P. E. Van Walderveen, C. S. Van Der Hooft


  • Open Access

    Effect of long-term treatment with galantamine on weight of patients with Alzheimer's dementia

    by E. Droogsma, D. Z. B. Van Asselt, J. H. M. Van Steijn, T. Schuur, E. J. Huinink


  • Open Access

    Assessment and treatment of malnutrition in Dutch geriatric practice: consensus through a modified Delphi study

    by Dieneke Z. B. van Asselt, Marian A. E. van Bokhorst-De van der Schueren, Tischa J. M. van der Cammen, Luc G. M. Disselhorst, Andre Janse, Sabine Lonterman-Monasch, Huub A. A. M. Maas, Miruna E. Popescu, Carla J. M. Schölzel-Dorenbos, Walter M. W. H. Sipers, et al.

    Objective: scientific evidence regarding the optimal management of malnutrition in geriatric patients is scarce. Our aim was to develop a consensus statement for geriatric hospital practice concerning six elements: (i) definition of malnutrition, (ii) screening and assessment, (iii) treatment and monitoring, (iv) roles and responsibilities of involved health care professionals, (v) communication and coordination of care between hospital and community health care professionals, (vi) quality indicators for malnutrition management. Design: a modified Delphi study. Methods: eleven geriatricians with special interest in malnutrition participated. In four rounds the experts rated the relevance of 204 statements, which were based on a literature review, on a five-point Likert scale. From the responses, means and 95% CIs were calculated. Consensus was defined as a lower 95% confidence limit ≥4.0. Results: the panel reached consensus that malnutrition should be considered a geriatric syndrome. The nutritional status should be assessed using the Mini Nutritional Assessment combined with comprehensive geriatric assessment. Nutritional interventions should be combined with interventions targeting underlying factors. Specific goals for nutritional therapy and ways to achieve them were agreed upon. According to the experts, malnutrition is best managed by a multidisciplinary team for whom roles and responsibilities were specified. At discharge written information about the nutritional problem, treatment plan and goals should be provided to the patient, caregiver and community health care professionals. Conclusion: this study shows that a qualitative study based on a modified Delphi technique can result in national consensus on essential ingredients for a practical malnutrition guideline for geriatric patients.


  • Cobalamin-binding proteins in normal and cobalamin-deficient older subjects

    by Dieneke Z.B. van Asselt, Chris M.G. Thomas, Martin F.G. Segers, Henk J. Blom, Ron A. Wevers, Willibrord H.L. Hoefnagels

    Background: The causes of cobalamin (vitamin B 12 ) deficiency in older people are only partly understood. We investigated the role of the cobalamin-binding proteins and tested the hypothesis that low saturated transcobalamin concentration is an early marker of cobalamin deficiency. Methods: We measured saturated (holo) and unsaturated (apo) transcobalamin and haptocorrin concentrations in healthy middle-aged volunteers, healthy older volunteers, cobalamin-deficient older volunteers and cobalamin-deficient older patients. Results: Holo and apo concentrations of transcobalamin and haptocorrin were similar in healthy middle-aged and older subjects. Holotranscobalamin concentrations were significantly decreased in cobalamin-deficient subjects but did not differ between healthy volunteers and patients. Furthermore, the relative amount of cobalamin on transcobalamin (i.e. holotranscobalamin/holotranscobalamin + holohaptocorrin) was similar in all four groups. Conclusions: Abnormalities of the cobalamin-binding proteins are not a cause of cobalamin deficiency in the aged. Plasma holotranscobalamin concentration did not differ between stages of cobalamin deficiency in older persons. Therefore, plasma holotranscobalamin is not an early marker of cobalamin deficiency in older people and has no additional value in the diagnostic work-up of reduced plasma cobalamin concentrations in older people.